Combined Autologous Breast Reconstruction and Gynecologic Procedures: Does Timing Affect Clinical and Patient‐Reported Outcomes?
Journal of Surgical Oncology · 2025
DOI: 10.1002/jso.28048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Janet C Coleman-Belin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Section of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Mammaplasty, Patient Reported Outcome Measures, Breast Neoplasms, Gynecologic Surgical Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748, which supports Memorial Sloan Kettering Cancer Center's research….
Abstract (Originalsprache)
Background
Patients with or at risk for breast cancer may opt for risk‐reducing gynecologic surgeries, including bilateral salpingo‐oophorectomies and/or total abdominal hysterectomy. The timing and safety of combining these procedures with autologous breast reconstruction (ABR) are debated. This study assesses the impact of concurrent ABR and gynecologic surgeries on clinical and patient‐reported outcomes.
Methods
Female patients who underwent ABR from 2010 to 2023 were included. Three groups were compared: (1) same‐day ABR with gynecologic surgery, (2) staged ABR and gynecologic surgery, and (3) ABR alone. Clinical and patient‐reported outcomes included operative time, length of stay (LOS), complications, return to the operating room, and BREAST‐Q Physical Well‐Being of the Abdomen scores.
Results
A total of 2288 patients were included. Of these, 66 had simultaneous surgeries (Group 1), 256 had staged surgeries (Group 2), and 1966 had ABR alone (Group 3). There were no meaningful differences in operative time, return to the operating room, LOS, or overall complication rates. Seroma occurrence was significantly lower in Group 3 than Group 2 (6.1% vs. 6.3% vs. 3.5%; p = 0.046) which emerged during pairwise comparisons. BREAST‐Q Physical Well‐Being of the Abdomen scores did not significantly differ among the three cohorts at preoperative, 6‐month postoperative, and 1‐year postoperative time points.
Conclusion
The findings indicate that simultaneous ABR and gynecologic surgeries do not significantly impact complication rates, operative times, hospital stays, or patient‐reported abdominal well‐being, supporting that simultaneous surgery as a safe and efficient approach for appropriate patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
ORCID-Profile: Robert J Allen
Förderung
- This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748, which supports Memorial Sloan Kettering Cancer Center's research…
Zitieren
APA
Coleman-Belin, J. C., Kim, M., Graziano, F. D., Boe, L. A., Khavanin, N., Massand, S., Nelson, J. A., & Allen, R. J. (2025). Combined Autologous Breast Reconstruction and Gynecologic Procedures: Does Timing Affect Clinical and Patient‐Reported Outcomes?. Journal of Surgical Oncology. https://doi.org/10.1002/jso.28048
Vancouver
Coleman-Belin JC, Kim M, Graziano FD, Boe LA, Khavanin N, Massand S, et al. Combined Autologous Breast Reconstruction and Gynecologic Procedures: Does Timing Affect Clinical and Patient‐Reported Outcomes?. Journal of Surgical Oncology. 2025. doi:10.1002/jso.28048
BibTeX
@article{ColemanBelin2025,
author = {Coleman-Belin, Janet C and Kim, Minji and Graziano, Francis D and Boe, Lillian A and Khavanin, Nima and Massand, Sameer and Nelson, Jonas A and Allen, Robert J},
title = {Combined Autologous Breast Reconstruction and Gynecologic Procedures: Does Timing Affect Clinical and Patient‐Reported Outcomes?},
journal = {Journal of Surgical Oncology},
year = {2025},
doi = {10.1002/jso.28048}
}
EUVIMED